J&J will pay royalties from use of tretinoin against photoaging to University of Pennsylvania and its affiliate University Patents. A March 4 settlement concludes a suit filed by Penn in 1989 against J&J and Albert Kligman, the discoverer of tretinoin while at the university. J&J has an existing royalty agreement with Penn for use of the product in acne, the currently approved indication.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth